Research progress of biological agents in thyroid-associated ophthalmopathy

Research progress of biological agents in thyroid-associated ophthalmopathy

Thyroid-associated ophthalmopathy(TAO)is a rare organ-specific autoimmune disease with an unclear pathogenesis. At present, the treatment still relies mainly on glucocorticoids and traditional immunosuppressants. However, some patients respond poorly to these drugs and experience treatment-related a...

Full description

Bibliographic Details
Main Authors: Zhao Jingxiao, Wang Ping, Jiang Minmin, Yan Shuxun
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2024-05-01
Series:Guoji Yanke Zazhi
Subjects:
thyroid-associated ophthalmopathy
biological agents
monoclonal antibodies
targeted therapy
drug therapy
Online Access:http://ies.ijo.cn/cn_publish/2024/5/202405021.pdf

Internet

http://ies.ijo.cn/cn_publish/2024/5/202405021.pdf

Similar Items